Skip to main content
Gilead Sciences Inc.
Healthcare · Drug Manufacturers - General
Made on Jun 28, 2026
Price at call $127.88
6-month call Bull +9.9%
Target by Dec 2026 $140.57
Great value below $108.00
Model v0.3.0

Projection vs Actual (6M history + forecast)

Our straight 6-month prediction (bold) with a textured realism line, and the actual price overlaid from the prediction date forward.

Forecast

One directional 6-month call and the six monthly points we'll be scored against. Predicted Jun 28, 2026 3:27 am
Bull GILD trends higher to $140.57 (+9.9% from $127.88) by Dec 2026.
Monthmonths after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $127.88 at call
Prediction made Jun 28, 2026 $127.88 at call
M1 Jul 28, 2026 $130.00 +1.7%
What actually happened: closed $130.52 on Jul 27, 2026 = +2.1% vs the call (predicted +1.7%)  ·  direction HIT (called flat, was flat)  ·  off by 0.4 pp  ·  accuracy 10/10  ·  S&P +0.8% over the same window — beat it
M2 Aug 28, 2026 $132.11 +3.3%
M3 Sep 28, 2026 $134.23 +5.0%
M4 Oct 28, 2026 $136.34 +6.6%
M5 Nov 28, 2026 $138.46 +8.3%
M6 Dec 28, 2026 $140.57 +9.9%

Deserved value (DCF/composite) is $161.07; over 6 months we project closing only part-way to it (reach 38.3%). Value-only — see Not Yet Modeled below.

Weaknesses

0 blocking · 0 degraded · 1 note — follow the chain top-down (cause → effect).
  • Note
    Valuation anchor absent: anchored_pe.
    anchor:anchored_pe

Equation Inputs

Everything feeding the v0.3.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$127.88
Composite fair value$129.29
Signal-adjusted fair value$130.35
DCF fair value$163.03
Anchored-PE fair value
Buy-below (value lens)$108.00
Value net score-39
Value confidence8 / 10
Quality net score+51
Memo confidence7 / 10
Deserved value (base)$146.16
Quality tilt+10.2%
Deserved value (used)$161.07
Coherence (value × quality)1.00

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 29.0%  3m 24.2%  6m 26.9%  
Daily σ (realism noise)1.5%
Beta vs S&P 500 1m 0.31  3m 0.49  5m 0.52  
Trailing 6-month return2.1%

Knobs (equation params)

Deserved wt · DCF0.5
Quality tilt cap (±)0.2
Horizon reach (6mo)0.45
Coherence floor (conflict)0.5
Conviction gain / pt0.06
Realism mean-reversion φ0.85
Conviction floor0.4
Deserved wt · composite0.5
Realism vol window3m
Neutral band (%)5
Horizon (months)6
Realism σ fallback0.015

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.3.0 #6bd904191719

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jun 28, 2026 freshest GILD-20260628-031422-91b9
ext-forensic-memo Jun 28, 2026 freshest ext-GILD-20260628-032511-bcfd
ext-lens-quality Jun 28, 2026 freshest ext-GILD-20260628-032511-bcfd
ext-lens-value Jun 28, 2026 freshest ext-GILD-20260628-032511-bcfd
scenario-valuation Jun 28, 2026 freshest GILD-20260628-031422-91b9
valuation-synthesis Jun 28, 2026 freshest GILD-20260628-031422-91b9

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 5, 2026 v0.6.0 Neutral $135.25 $139.50 +3.1% Feb 2027 view
Jun 28, 2026 v0.3.0 Bull $127.88 $140.57 +9.9% Dec 2026 viewing

Not Yet Modeled

What this v0.3.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Signal-adjusted fair value ($130.35) — the red-flag-adjusted anchor isn't the primary input yet (we use the raw DCF/composite blend, which double-counts DCF).
  • Recent momentum / drift — the line takes off straight; the trailing 6-month move (2.1%) doesn't bend the slope.
  • Market beta — computed (1–5mo) for context but does not condition the path.
  • Earnings dates, catalysts, and known events — not modeled.
  • Macro regime & sector rotation — not modeled.
  • Horizon is a fixed 6-month assumption, not a modeled time-to-target.
  • Outcome scoring — predictions aren't yet graded against realized price once the evaluation date passes.